Patents Assigned to CERO THERAPEUTICS, INC.
  • Chimeric engulfment receptor molecules and methods of use
    Patent number: 11708423
    Abstract: The present disclosure relates to chimeric engulfment receptor molecules, host cells modified to include the phagocytic engulfment molecules, and methods of making and using such receptor molecules and modified cells.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: July 25, 2023
    Assignee: CERO THERAPEUTICS, INC.
    Inventor: Daniel Mark Corey
  • Chimeric engulfment receptor molecules
    Patent number: 11655282
    Abstract: The present disclosure relates to chimeric engulfment receptor molecules, host cells modified to include the phagocytic engulfment molecules, and methods of making and using such receptor molecules and modified cells.
    Type: Grant
    Filed: August 11, 2021
    Date of Patent: May 23, 2023
    Assignee: CERO THERAPEUTICS, INC.
    Inventor: Daniel Mark Corey